Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.087 USD | +6.36% | +21.00% | +81.25% |
05-01 | BetterLife Pharma Advances IND-enabling Studies For BETR-001 | MT |
04-03 | BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.32M 18.19M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.39M | Net income 2023 | -9M -12.3M | EV / Sales 2022 | - |
Net Debt 2022 | 139K 190K | Net Debt 2023 | 71.69K 97.95K | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-1.36
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.36% |
1 day | +6.36% | ||
1 week | +21.00% | ||
Current month | +24.29% | ||
1 month | +17.89% | ||
3 months | +55.36% | ||
6 months | +99.54% | ||
Current year | +81.25% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 10-12-25 |
Chief Operating Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 15-02-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.087 | +6.36% | 25,346 |
24-05-01 | 0.0818 | -1.33% | 25,144 |
24-04-30 | 0.0829 | +10.09% | 33,622 |
24-04-29 | 0.0753 | -1.62% | 8,218 |
24-04-26 | 0.0765 | +6.45% | 6,653 |
Delayed Quote OTC Markets, May 02, 2024 at 03:59 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+81.25% | 9.49M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- BETR.F Stock